7 news items
Jennifer Schneider Elected to Vertex Board of Directors
VRTX
15 May 24
as an independent director. Dr. Schneider has more than two decades of experience in the health care industry as a physician, scientist and health care executive
Vertex Reports First Quarter 2024 Financial Results
VRTX
6 May 24
of the unblinded data reviewed by the Independent Data Safety Monitoring Committee (IDMC), Vertex advanced into the Phase 3 portion of the global Phase 2/3
Reported Earlier, Vertex Advances Inaxaplin Into Phase 3 Portion Of Adaptive Phase 2/3 Clinical Trial For The Treatment Of APOL1-Mediated Kidney Disease
VRTX
1 Apr 24
by inaxaplin's potential, which energizes those of us caring for patients with AMKD."An Independent Data Monitoring Committee (IDMC) reviewed
Revolutionizing Targeted Cancer Treatment and Radiotherapy Manufacturing: Actinium Pharmaceuticals (NYSE: ATNM) Trailblazing Journey
ARGX
ATNM
MRNA
28 Mar 24
is neither an investment advisor nor a registered broker. No current owner, employee, or independent contractor of InvestorBrandMedia.com
Actinium Pharmaceuticals (ATNM): A Prime Buyout Candidate Amidst a Radiopharma Acquisition Wave
ARGX
ATNM
AZN
26 Mar 24
, employee, or independent contractor of InvestorBrandMedia.com is registered as a securities broker-dealer, broker, investment advisor, or IA representative
1z9ka4d dumintsso99gr0splwfqxr7e5ez
ATNM
AZN
BMY
25 Mar 24
shares of ATNM. InvestorBrandMedia.com is neither an investment advisor nor a registered broker. No current owner, employee, or independent contractor
e5bquvc6ghgpkhw
ARGX
ATNM
AZN
22 Mar 24
zero shares of ATNM. InvestorBrandMedia.com is neither an investment advisor nor a registered broker. No current owner, employee, or independent
- Prev
- 1
- Next